| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.52B | 14.99B | 14.46B | 13.80B | 13.74B | 15.01B |
| Gross Profit | 1.50B | 915.00M | 1.46B | 1.41B | 1.73B | 2.24B |
| EBITDA | 1.33B | 1.40B | 1.31B | 1.20B | 1.45B | 1.95B |
| Net Income | 591.00M | 204.00M | 553.00M | 459.00M | 683.00M | 1.01B |
Balance Sheet | ||||||
| Total Assets | 25.39B | 26.68B | 26.14B | 25.21B | 24.73B | 24.67B |
| Cash, Cash Equivalents and Short-Term Investments | 841.00M | 354.00M | 2.55B | 6.45B | 9.50B | 9.45B |
| Total Debt | 1.00M | 0.00 | 1.00M | 2.00M | 3.00M | 5.00M |
| Total Liabilities | 2.78B | 3.65B | 3.63B | 3.05B | 3.08B | 3.48B |
| Stockholders Equity | 22.60B | 23.02B | 22.50B | 22.16B | 21.65B | 21.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.08B | -3.62B | -2.85B | 387.00M | 1.11B |
| Operating Cash Flow | 0.00 | -238.00M | 1.41B | 914.00M | 1.06B | 1.43B |
| Investing Cash Flow | 0.00 | -1.66B | -4.12B | -4.39B | -733.00M | -320.00M |
| Financing Cash Flow | 0.00 | -278.00M | -278.00M | -278.00M | -277.00M | -277.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥22.68B | -13.86 | ― | 1.87% | 4.26% | 27.55% | |
65 Neutral | ¥13.64B | 9.53 | ― | 1.43% | 5.88% | 180.90% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥35.00B | 4.55 | ― | 0.80% | 12.41% | 129.01% | |
48 Neutral | ¥14.10B | 51.12 | ― | 1.61% | 2.00% | -44.01% | |
46 Neutral | ¥34.17B | 21.75 | ― | 1.65% | -1.17% | -95.57% | |
46 Neutral | ¥13.66B | -20.95 | ― | 1.90% | 3.69% | -63.11% |